Improved radiotracing of oxytocin receptor-expressing tumours using the new [(111)In]-DOTA-Lys(8)-deamino-vasotocin analogue

Oxytocin receptors (OTR) have been described in a number of tumours of different origin, and represent a new target for specific radiolabelled oxytocin (OT) analogues in cancer diagnosis and therapy. By linking the DOTA chelating agent to position 8 of the deamino derivative of Lys(8)-vasotocin (dLV...

Descripción completa

Detalles Bibliográficos
Autores principales: Chini, B, Chinol, M, Cassoni, P, Papi, S, Reversi, A, Areces, L, Marrocco, T, Paganelli, G, Manning, M, Bussolati, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394487/
https://www.ncbi.nlm.nih.gov/pubmed/12942128
http://dx.doi.org/10.1038/sj.bjc.6601189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394487/
https://www.ncbi.nlm.nih.gov/pubmed/12942128
http://dx.doi.org/10.1038/sj.bjc.6601189

Ejemplares similares